A revolutionary new prostate treatment is being rolled out across the UK, with nine hospitals set to offer a non-invasive option to stop thousands of men being left with gruelling side effects from surgery.
Every year, up to 12,000 men with early-stage prostate cancer will receive the same invasive treatment as those with advanced cancer, which often leads to urinary and erectile dysfunction.
But a new focal therapy that uses high focused beams of ultrasound (HIFU) or cryotherapy to target and treat the cancer leaving surrounding organs and tissue unharmed, is set to offer a new lifeline.
